Impax Laboratories ( IPXL) is a technology-based, specialty pharmaceutical company focused on the development and commercialization of bioequivalent and brand-name pharmaceuticals. This stock is trading up 4.7% at $26.01 in recent trading. Today's Volume: 816,000 Average Volume: 536,486 Volume % Change: 184% >>5 Stocks With Big Insider Buying From a technical perspective, IPXL is ripping higher here above-average volume, and its trending into breakout territory above some near-term overhead resistance levels at $25.31 to $25.36. At last check, IPXL has hit an intraday high of $26.08 and volume is well above its three-month average action of 536,486 shares. Traders should now look for long-biased trades in IPXL as long as its trending above today's low of $24.75 with strong upside volume flows. I would consider any upside volume day that registers near or above 536,486 shares as bullish. If IPXL can hold that trend, and especially hold its trend above those breakout levels, then this stock has a great chance of re-testing or taking out its next major overhead resistance levels at $27 to $28.75 in the near future.